JACKSONVILLE, FL — Johnson & Johnson Vision announced that the U.S. Food and Drug Administration has approved Acuvue Abiliti Overnight Therapeutic Lenses for myopia management.
Abiliti Overnight orthokeratology lenses are designed and fitted to match a patient’s eye based on its unique corneal shape to temporarily reshape the cornea. The product is expected to be available in the U.S. by the end of 2021.
“The FDA approval of Abiliti Overnight lenses marks an important milestone in our commitment to help change the trajectory of eye health,” said Xiao-Yu Song, MD, PhD, global head of research and development, Johnson & Johnson Vision. “We look forward to supporting patients and eye care professionals with comprehensive resources, starting with Abiliti Overnight lenses, and continuing with additional products and services to address myopia management.”
Abiliti Overnight lenses are optimized by the use of corneal topography, refractive error and other measurements connected to an experiential fitting software, FitAbiliti. The FitAbiliti software guides the eyecare professional through the fitting process and recommends a lens with the first fit success rate of about 90%, according to a press release from Johnson & Johnson Vision. The lenses will be available in two different contact lens designs: Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management, and Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management for Astigmatism.
“The prevalence of myopia in children is increasing, and as optometrists we are on the front lines of this epidemic that may threaten the vision of future generations,” said Moshe Mendelson, OD, FIAO. “The FDA approval of Abiliti Overnight lenses will provide eyecare professionals and parents with more options to manage myopia.”
The FDA approval of Abiliti Overnight lenses stems from the collaboration of Johnson & Johnson Vision with Menicon.
Each annual purchase of an Abiliti product will provide a free comprehensive eye health exam to a child in need through Sight For Kids, a joint program from Johnson & Johnson Vision and the Lions Clubs International Foundation.